Its oral formulation lowers barriers to early GLP-1RA initiation, improves patient acceptance, and enables intensification of therapy across the spectrum of type 2 diabetesincluding patients on insulin and those with moderate renal impairmentwithout increasing hypoglycemia risk
Tirzepatide, also known by the brand names Mounjaro and Zepbound, is an FDA-approved dual-action GLP-1/GIP receptor agonist made by Eli Lilly
Gong, C
With many plans, including major providers like UnitedHealthcare, Cigna, Aetna, and government options like Medicare Part D and Medicaid, covering weight loss medications, Klinic ensures all logistics are handled
S.FarhangiM.RafieeG
We are delighted that Brazilian consumers looking to fight free radical damage will now have access to Setria, said Karen Todd, MBA, RD, vice president of global brand marketing